Published in TB and Outbreaks Week, October 9th, 2001
More than 700 patients were enrolled in this first trial (CAP1), which is an international, randomized, prospective, double-blinded study. The trial is being conducted predominantly in the Northern...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week